Literature DB >> 2731177

Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells.

S Yagel1, A H Warner, H N Nellans, P K Lala, C Waghorne, D T Denhardt.   

Abstract

Cysteine proteinases, particularly cathepsins B and L, have been strongly implicated in fostering metastasis in mice. In this work four different inhibitors of cysteine proteinases have been shown to inhibit the invasion of the human amnion by murine melanoma and mammary carcinoma cells in vitro. Two of the inhibitors are synthetic peptides [ZPhePheCHN2 (benzyloxycarbonyl-L-phenylalanyl-L-phenylalanyldiazomethane) and ZPheAlaCH2F [3-(N-benzyloxycarbonylphenylalanylamido)-DL-1-fluoro-2-butanone]] and two are thiol protease inhibitors (TPIn, TPId) isolated from the skeletal muscle of the hind limbs of normal and dystrophic mice, respectively. The inhibitors (ZPhePheCHN2, TPId), with apparent selectivity for cathepsin L, blocked invasion as effectively as inhibitors (ZPheAlaCH2F, TPIn) effective on both cathepsins. The data reveal that in these cell lines the cysteine proteinases contribute significantly to the invasive capacity of the cells, but to a lesser extent than do the metalloproteinases. We suggest that the cysteine proteinases facilitate the action of metalloproteinases (collagenase, gelatinase, and stromelysin), possibly by activating them, by inactivating the tissue inhibitor of metalloproteinases, and/or by making basement membrane matrix more accessible.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731177

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Ca&sup2+;-Dependent Neutral Protease (Calpain) Activity in Breast Cancer Tissue and Estrogen Receptor Status.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

Review 2.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

3.  Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth.

Authors:  Elisa Giannoni; Francesca Buricchi; Giovanni Raugei; Giampietro Ramponi; Paola Chiarugi
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

4.  Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress.

Authors:  Manti Guha; Satish Srinivasan; Gopa Biswas; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

5.  Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress.

Authors:  Manti Guha; Hua Pan; Ji-Kang Fang; Narayan G Avadhani
Journal:  Mol Biol Cell       Date:  2009-07-29       Impact factor: 4.138

6.  Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.

Authors:  R Coulombe; P Grochulski; J Sivaraman; R Ménard; J S Mort; M Cygler
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

Review 7.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 8.  The evolution of proteinase substrates with special reference to dipeptidylpeptidase IV.

Authors:  R E Smith; C J Reynolds; E A Elder
Journal:  Histochem J       Date:  1992-09

9.  Chloramphenicol causes mitochondrial stress, decreases ATP biosynthesis, induces matrix metalloproteinase-13 expression, and solid-tumor cell invasion.

Authors:  Ching-Hao Li; Yu-Wen Cheng; Po-Lin Liao; Ya-Ting Yang; Jaw-Jou Kang
Journal:  Toxicol Sci       Date:  2010-03-25       Impact factor: 4.849

10.  Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth.

Authors:  E Weber; D Günther; F Laube; B Wiederanders; H Kirschke
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.